Clinical trials
Terminated Phase 2 Prostatic Hyperplasia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2008 | 2 |
| 2010 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 1 |
| Eli Lilly and Company | 1 |
| OPKO Health, Inc. | 1 |
| Organon and Co | 1 |
| Oxford BioMedica | 1 |
| QLT Inc. | 1 |
| South Florida Medical Imaging, PA | 1 |
| Spectrum Pharmaceuticals, Inc | 1 |
| Threshold Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 9 |
| Lower Urinary Tract Symptoms | 2 |
| Prostatic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.